BBI Life Sciences Corporation announced that at its AGM held on 29 June 2018, the shareholders approved the final dividend of HKD 0.014 per share for the year ended 31 December 2017 to shareholders whose names appear on the register of members of the company on 6 July 2018. It is expected that the dividend warrants will be posted by ordinary mail to shareholders who are entitled to receive the dividend at their own risk on or around 31 July 2018.